In this issue of Rheumatology Nurse Practice, we will explore the prevalence of comorbidities in patients with psoriatic arthritis, review some of the key screening components of which clinicians should be mindful and discuss treatment considerations in the presence of some of the more common and significant comorbidities.
Carrie Beach, BSN, RN-BC
Board Certified in Rheumatology Nursing
Staff Rheumatology Nurse
Columbus Arthritis Center
Nancy Eisenberger, MSN, APRN, FNP-C
Arthritis, Rheumatic and Back Disease Associates
Voorhees, New Jersey
Teri Puhalsky, BSN, RN, CRNI
Medstar Orthopedic Institute
This activity has been designed to meet the educational needs of nurses, nurse practitioners, and
physician assistants. Other healthcare providers may also participate.
After participating in the activity, learners should be better able to:
- Identify the most common comorbidities among patients diagnosed with psoriatic arthritis (PsA)
- Analyze the clinical impact of expert guidance regarding the screening and treatments of these comorbidities
- Discuss the importance of mental health on overall patient outcomes in PsA
- Develop plans to incorporate or enhance screening practices for comorbidities among your patients with PsA
Accreditation and Credit Designation:
The Rheumatology Nurses Society is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500)
Participants will receive 2.75 hours of continuing nursing contact hours, including 2.0 pharmacotherapeutic contact hours, by completing the education, completing an online evaluation, and receiving a post-test score of 70%.
According to the disclosure policy of the Rheumatology Nurses Society, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Relationships are abbreviated as follows: E, Educational planning committee; G, Grant/research support recipient; A, Advisor/review panel member; C, Consultant; S, Stock shareholder; SB, Speaker bureau; PE, Promotional event talks; H, Honoraria; O, Other.
Planners, reviewers, and faculty have disclosed no conflicts of interest related to the content of this education, with the exception of the following:
Carrie Beach, RN-BC, BSN, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Mallinckrodt, Gilead/C.
Nancy Eisenberger, MSN, APRN, FNP-C, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Janssen/SB, C; Crescendo/SB; AbbVie/C.
Method of Participation:
There are no fees to participate in the activity. Participants must review the activity information, including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please go to rnsnurse.com/rnpce and complete the post-test (achieving a passing grade of 70% or greater) and program evaluation. Your certificate will be available to you upon completion.
© 2021. This CNE-certified activity is held as copyrighted © by Rheumatology Nurses Society. Through this notice, the Rheumatology Nurses Society grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Expiration: This course will expire on April 30th, 2022